These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 445031)
21. Gross oedema occurring during treatment for depression. Goonewardene A; Toghill PJ Br Med J; 1977 Apr; 1(6065):879-80. PubMed ID: 851766 [No Abstract] [Full Text] [Related]
22. Use of MAO inhibitors in elderly patients. Ashford JW; Ford CV Am J Psychiatry; 1979 Nov; 136(11):1466-7. PubMed ID: 495803 [No Abstract] [Full Text] [Related]
23. Urinary amine metabolite excretion in a patient with adrenergic hyperactivity state: reaction to phenelzine withdrawal and combined treatment. Modai I; Beigel Y; Cygielman G J Clin Psychiatry; 1986 Feb; 47(2):92-3. PubMed ID: 2418010 [TBL] [Abstract][Full Text] [Related]
24. A follow-up study on the chemotherapy of neurodermatitis with a monoamine oxidase inhibitor. Friedman S; Kantor I; Sobel S; Miller R J Nerv Ment Dis; 1978 May; 166(5):349-57. PubMed ID: 650199 [No Abstract] [Full Text] [Related]
30. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor. Goff DC Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318 [TBL] [Abstract][Full Text] [Related]
31. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression. Merikangas KR; Merikangas JR Biol Psychiatry; 1995 Nov; 38(9):603-10. PubMed ID: 8573662 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic re-orientation in some depressive states: clinical evaluation of a new mono-amine oxidase inhibitor (W-1554-A, phenelzine, Nardil). FURST W Am J Psychiatry; 1959 Nov; 116():429-34. PubMed ID: 13825724 [No Abstract] [Full Text] [Related]
33. Phenelzine treatment of selective mutism in four prepubertal children. Golwyn DH; Sevlie CP J Child Adolesc Psychopharmacol; 1999; 9(2):109-13. PubMed ID: 10461821 [TBL] [Abstract][Full Text] [Related]
34. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors. Georgotas A; Friedman E; McCarthy M; Mann J; Krakowski M; Siegel R; Ferris S Biol Psychiatry; 1983 Feb; 18(2):195-205. PubMed ID: 6830930 [TBL] [Abstract][Full Text] [Related]
35. Tolerance to phenelzine and subsequent refractory depression: three cases. Donaldson SR J Clin Psychiatry; 1989 Jan; 50(1):33-5. PubMed ID: 2910838 [TBL] [Abstract][Full Text] [Related]
37. Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: relevance to atypical depression. Kier A; Han J; Jacobson L Endocrinology; 2005 Mar; 146(3):1338-47. PubMed ID: 15564336 [TBL] [Abstract][Full Text] [Related]
38. Anesthesia for cardiac surgery in patients receiving monoamine oxidase inhibitors. Michaels I; Serrins M; Shier NQ; Barash PG Anesth Analg; 1984 Nov; 63(11):1041-4. PubMed ID: 6333833 [No Abstract] [Full Text] [Related]
39. Central nervous system toxicity after abrupt monoamine oxidase inhibitor switch: a case report. Safferman AZ; Masiar SJ Ann Pharmacother; 1992 Mar; 26(3):337-8. PubMed ID: 1554951 [TBL] [Abstract][Full Text] [Related]